Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
6.73
+0.67 (10.97%)
At close: May 15, 2025, 4:00 PM
6.65
-0.07 (-1.12%)
After-hours: May 15, 2025, 7:58 PM EDT
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $724.54 million as of May 15, 2025. Its market cap has decreased by -63.36% in one year.
Market Cap
724.54M
Enterprise Value
431.73M
1-Year Change
-63.36%
Ranking
Category
Stock Price
$6.73
Market Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $724.54M, an increase of 660.27%. That is a compound annual growth rate of 21.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2025 | 652.40M | -43.06% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.57B |
| Johnson & Johnson | 358.65B |
| AbbVie | 315.80B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 243.43B |
| Abbott Laboratories | 230.27B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |